On CNBC’s “Mad Money Lightning Round,” Jim Cramer said MicroStrategy Incorporated MSTR is a Bitcoin play and he prefers to actually own Bitcoin BTC/USD.
MicroStrategy announced it completed its previously announced offering of its 0% convertible senior notes due 2029. MicroStrategy said the aggregate principal amount of the notes sold in the offering was $3 billion, which includes $400 million aggregate principal amount of notes issued pursuant to an option to purchase.
When asked about Oscar Health, Inc. OSCR, he said, “Until I saw that Mark Bertolini is the CEO, I didn’t really have much in store for this. But Bertolini’s a winner and a hitter.”
On Nov. 7, Oscar Health reported a quarterly loss of 22 cents per share which missed the analyst consensus estimate of a loss of 19 cents per share. The company reported quarterly sales of $2.42 billion which beat the analyst consensus estimate of $2.34 billion.
CNH Industrial N.V. CNH is a “second-rater,” Cramer said. “I want to go with best of breed, and best of breed is John Deere DE.”
On Nov. 7, CNH Industrial reported worse-than-expected third-quarter EPS results and also lowered FY24 adjusted EPS outlook.
“The former, BGS, is a total loser and has been a loser for many, many years,” Cramer said when asked about B&G Foods, Inc. BGS.
On Nov. 5, B&G Foods reported worse-than-expected third-quarter financial results and issued FY24 net sales guidance below estimates.
When asked about Rocket Lab USA, Inc. RKLB, he said, “It’s moth to flame, but I don’t know how close the moth is to the flame.”
On Nov. 19, Goldman Sachs analyst Noah Poponak maintained Rocket Lab with a Neutral and raised the price target from $5 to $12.
Price Action:
- Oscar Health shares fell 4.1% to settle at $16.31 on Thursday.
- CNH Industrial shares gained 4.6% to close at $11.92.
- Rocket Lab shares gained 11.1% to close at $22.41.
- MicroStrategy shares fell 16.2% to settle at $397.28 during the session.
Read Next:
Image: Shutterstock
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
